Details for Patent: 5,698,226
✉ Email this page to a colleague
Summary for Patent: 5,698,226
Title: | Water-dispersible tablets |
Abstract: | A water-dispersible tablet comprises an active compound such as acyclovir or lamotrigine and a dispersing agent. The dispersing agent is a swellable clay such as a smectite, e.g. Veegum F or bentonite, and is generally present within the granules of the tablet to provide a tablet which is capable of dispersing in water within 3 minutes to provide a dispersion which will pass through a 710 .mu.m sieve. The tablet can be optionally film-coated in which case the dispersion time is less than 5 minutes. |
Inventor(s): | Fielden; Krystyna Elzbieta (Dartford, GB) |
Assignee: | Glaxo Wellcome Inc. (Research Triangle Park, NC) |
Application Number: | 08/659,316 |
Patent Claim Types: see list of patent claims | Formulation; Dosage form; Device; Composition; |
Drugs Protected by US Patent 5,698,226
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |